Treatment of Persistent Postpartum Bleeding Associated with Retained Placental Tissue with a Gonadotropin Releasing Hormone Agonist together with an Aromatase Inhibitor and Tranexamic Acid: Experience with 2 Cases and Review of the Literature

Review Of The Literature ◽

Releasing Hormone ◽

Postpartum Bleeding ◽

Retained Placental Tissue

Resolution of Uterine Arterio-Venous Malformation Followed by Uneventful Pregnancy after Administration of Gonadotropin Releasing Hormone Agonist Concomitantly with an Aromatase Inhibitor and Tranexamic Acid

International Journal of Women s Health and Wellness ◽

10.23937/2474-1353/1510056 ◽

2017 ◽

Vol 3 (3) ◽

Cited By ~ 1

Author(s):

George A Vilos

Keyword(s):

Tranexamic Acid ◽

Aromatase Inhibitor ◽

Venous Malformation ◽

Releasing Hormone ◽

Arterio Venous Malformation ◽

Uneventful Pregnancy

Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist

Fertility and Sterility ◽

10.1016/j.fertnstert.2006.09.010 ◽

2007 ◽

Vol 87 (6) ◽

pp. 1468.e9-1468.e12 ◽

Cited By ~ 15

Author(s):

Fuminori Kimura ◽

Kentaro Takahashi ◽

Koichi Takebayashi ◽

Mutsuko Fujiwara ◽

Nobuyuki Kita ◽

...

Keyword(s):

Aromatase Inhibitor ◽

Premenopausal Woman ◽

Concomitant Treatment ◽

Releasing Hormone ◽

Uterine Adenomyosis

A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status

Fertility and Sterility ◽

10.1016/j.fertnstert.2008.09.064 ◽

2010 ◽

Vol 93 (1) ◽

pp. 192-198 ◽

Cited By ~ 99

Author(s):

Mohammad Ebrahim Parsanezhad ◽

Mina Azmoon ◽

Saeed Alborzi ◽

Abdoreza Rajaeefard ◽

Afsun Zarei ◽

...

Keyword(s):

Clinical Trial ◽

Aromatase Inhibitor ◽

Uterine Leiomyoma ◽

Controlled Clinical Trial ◽

Hormonal Status ◽

Randomized Controlled Clinical Trial ◽

Releasing Hormone ◽

Randomized Controlled

Gonadotropin-releasing Hormone Agonist Plus Aromatase Inhibitor in the Treatment of Uterine Leiomyoma in Near Menopause Patient: A Case Series Study

Journal of Menopausal Medicine ◽

10.6118/jmm.2018.24.1.62 ◽

2018 ◽

Vol 24 (1) ◽

pp. 62

Author(s):

Sanam Moradan

Keyword(s):

Aromatase Inhibitor ◽

Uterine Leiomyoma ◽

Case Series ◽

Releasing Hormone ◽

Case Series Study ◽

Series Study

Pretreatment with a gonadotropin-releasing hormone agonist and an aromatase inhibitor may improve outcomes in in vitro fertilization cycles of women with stage I–II endometriosis

F&S Science ◽

10.1016/j.xfss.2020.06.005 ◽

2020 ◽

Vol 1 (1) ◽

pp. 98-103

Author(s):

Sabrina Piedimonte ◽

Alexander Volodarsky-Perel ◽

Samer Tannus ◽

Seang Lin Tan ◽

Michael H. Dahan

Keyword(s):

In Vitro Fertilization ◽

Aromatase Inhibitor ◽

Gonadotropin Releasing Hormone Agonist

Stage I ◽

Vitro Fertilization ◽

Releasing Hormone ◽

A pilot study of gonadotropin-releasing hormone agonist combined with aromatase inhibitor as fertility-sparing treatment in obese patients with endometrial cancer

Journal of Gynecologic Oncology ◽

10.3802/jgo.2019.30.e61 ◽

2019 ◽

Vol 30 (4) ◽

Cited By ~ 4

Author(s):

Zhibo Zhang ◽

Huifang Huang ◽

Fengzhi Feng ◽

Jinhui Wang ◽

Ninghai Cheng

Keyword(s):

Endometrial Cancer ◽

Pilot Study ◽

Aromatase Inhibitor ◽

Obese Patients ◽

Releasing Hormone ◽

Fertility Sparing

The combination of gonadotropin releasing hormone agonist and levonorgestrel-release intrauterine device/aromatase inhibitor for severe atypical hyperplasia and well-differentiated endometrial carcinoma

Gynecologic Oncology ◽

10.1016/j.ygyno.2017.03.220 ◽

2017 ◽

Vol 145 ◽

pp. 94

Author(s):

M. Yu

Keyword(s):

Aromatase Inhibitor ◽

Endometrial Carcinoma ◽

Intrauterine Device ◽

Atypical Hyperplasia ◽

Releasing Hormone ◽

Well Differentiated

Management of recurrent implantation failure by gonadotropin-releasing hormone agonist and aromatase inhibitor suppression, in women without evidence of endometriosis

Gynecological Endocrinology ◽

10.1080/09513590.2018.1519790 ◽

2018 ◽

Vol 35 (3) ◽

pp. 267-270 ◽

Cited By ~ 2

Author(s):

S. Khayat ◽

B. Elliott ◽

M. H. Dahan

Keyword(s):

Aromatase Inhibitor ◽

Gonadotropin Releasing Hormone Agonist

Implantation Failure ◽

Recurrent Implantation Failure ◽

Releasing Hormone ◽

Preliminary clinical application of an aromatase inhibitor and a gonadotropin-releasing hormone agonist combination for inoperable endometrial cancer patients with comorbidities: case report and literature review

Cancer Biology & Therapy ◽

10.1080/15384047.2018.1456609 ◽

2018 ◽

Vol 19 (11) ◽

pp. 956-961

Author(s):

Mengting Dong ◽

Su Jiang ◽

Wenyan Tian ◽

Ye Yan ◽

Chao Gao ◽

...

Keyword(s):

Endometrial Cancer ◽

Case Report ◽

Literature Review ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Clinical Application ◽

Gonadotropin Releasing Hormone Agonist

Releasing Hormone ◽

Prediction of ovarian function recovery after ovarian protection with gonadotropin-releasing hormone agonist during chemotherapy in young breast cancer patients

10.26226/morressier.5912d9ebd462b802923862c7 ◽

2017 ◽

Author(s):

Dong-Yun Lee

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Ovarian Function ◽

Breast Cancer Patients ◽

Releasing Hormone ◽

Ovarian Protection ◽

Function Recovery ◽

Young Breast Cancer